Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure

AIMS: Phosphodiesterase‐5 inhibitors (PDE5I) are frequently implemented after left ventricular assist device (LVAD) implantation to improve haemodynamics in patients with early postoperative right ventricular (RV) failure. It is unknown if long‐term PED5I therapy beyond the early post‐operative peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Papathanasiou, Maria, Jakstaite, Aiste‐Monika, Mincu, Raluca, Wernhart, Simon, Ruhparwar, Arjang, Rassaf, Tienush, Luedike, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375110/
https://www.ncbi.nlm.nih.gov/pubmed/37056058
http://dx.doi.org/10.1002/ehf2.14366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375110/
https://www.ncbi.nlm.nih.gov/pubmed/37056058
http://dx.doi.org/10.1002/ehf2.14366

Ejemplares similares